Clinical Trials Browser

Phase 2 × Lymphoma × Potassium Iodide × Clear all

NCT00490009 2017-03-30

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

Phase 2 Completed

9 enrolled 10 charts

Lymphoma